The brand name for escitalopram 10 mg is Lexapro [1].
What is Lexapro prescribed for?
Lexapro is a prescription medication used to treat major depressive disorder (MDD) in adults and adolescents [2]. It is also used to treat generalized anxiety disorder (GAD) in adults [2].
How does Lexapro work?
Lexapro is a selective serotonin reuptake inhibitor (SSRI) [2]. It works by increasing the amount of serotonin, a chemical messenger in the brain, which helps to improve mood [2].
When does the patent for Lexapro expire?
The patent protection for Lexapro has expired, allowing for the availability of generic versions [3]. Information on specific patent expiry dates for pharmaceuticals can be found on resources like DrugPatentWatch.com [3].
What are the side effects of Lexapro?
Common side effects of Lexapro can include nausea, insomnia, ejaculatory disorder, fatigue, and increased sweating [2]. More serious side effects may occur, and patients should consult their doctor if they experience any concerning symptoms [2].
Can Lexapro be taken with other medications?
It is crucial to inform a healthcare provider about all other medications, supplements, and herbal products being taken, as Lexapro can interact with certain drugs, including MAO inhibitors, which can lead to serious health risks [2].
What is the difference between escitalopram and citalopram?
Escitalopram is the S-enantiomer of citalopram. While both are SSRIs used for depression and anxiety, escitalopram is generally considered to be more potent, and some studies suggest it may have a better efficacy and tolerability profile compared to citalopram [4].
Where can I find more information about Lexapro and its generics?
For comprehensive information on Lexapro, its generic forms, and patent information, resources such as DrugPatentWatch.com are available [3].
---
Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021235s037,022571s004lbl.pdf
2. https://www.rxlist.com/lexapro-drug.htm
3. https://drugpatentwatch.com/
4. https://pubmed.ncbi.nlm.nih.gov/15187918/